Concepedia

Author

Ludovica Marando

University of CambridgeORCID

Also Known As

Ludovica Marando

64

Publications

1.2K

Citations

12

H-Index

14

Concepts

All Affiliations

University of CambridgeWellcome/MRC Cambridge Stem Cell InstituteWellcome Sanger InstituteCancer Research UK Cambridge CenterUniversidad de Oviedo
LM

About

Ludovica Marando is an author at University of Cambridge specializing in genetic variation, genomics, and epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

44

2

Public Health

1

1

44

3

Epidemiology

1

1

44

4

Pathology

1

1

44

5

Epigenetics

1

1

44

Ludovica Marando

×

11

Publications

1.1K

Citations

10

H-Index

YearCitations

Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab

Antonio M. Risitano, Rosario Notaro, Ludovica Marando,

Blood

2009

339

Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy

Dorian Forte, María García‐Fernández, Abel Sánchez‐Aguilera,

Cell Metabolism

2020

197

Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition

Paolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis,

Blood

2018

148

Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

Faisal Basheer, George Giotopoulos, Eshwar Meduri,

The Journal of Experimental Medicine

2019

118

Multiparameter prediction of myeloid neoplasia risk

Muxin Gu, Sruthi Cheloor Kovilakam, William G. Dunn,

Nature Genetics

2023

93

Prevalence and significance of <i>DDX41</i> gene variants in the general population

Sruthi Cheloor Kovilakam, Muxin Gu, William G. Dunn,

Blood

2023

44

Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression

Haiyang Yun, Nisha Narayan, Shabana Vohra,

Nature Genetics

2021

36

A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies

Mark A. Dawson, Gautam Borthakur, Brian J.P. Huntly,

Clinical Cancer Research

2022

31

Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis

Malgorzata Gozdecka, Monika Dudek, Sean Wen,

Nature

2025

25

Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes

Tomoya Isobe, Iwo Kuciński, Melania Barile,

Cell Genomics

2023

12

Page 1